Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

Sycor - Philippines FDA Drug Approval Details

Approvals/Philippines FDA/Sycor

Approved

STANDARD

Sycor

Claris Injectables Limited🇵🇭 Food and Drug Administration - Philippines

Approval Date: Jul 14, 2025
Approval ID: 5007de72cc90ec9f
Company: Claris Injectables Limited
Type: Standard

Approval Details

Approval Id: 5007de72cc90ec9f
Drug Approval Philippines Name: Sycor
Product Name: Sycor
Registration Number: DRP-7639
Brand Name: Sycor
Generic Name: Aciclovir
Dosage Form: Solution For Iv Infusion
Dosage Strength: 25mg/mL
Manufacturer: Claris Injectables Limited
Importer: Claris Lifesciences Philippines, Inc.
Distributor: Claris Lifesciences Philippines, Inc.
Issuance Date: 28 July 2021
Expiry Date: 14 December 2026
Pharmacologic Category: Antiviral
Classification: Prescription Drug (RX)

Active Ingredients

Approved

Quick Info

Agency

Philippines FDA

Country

🇵🇭

Approval Date

Jul 14, 2025

Approval ID

5007de72cc90ec9f

Type

Standard

Back to Philippines FDA Approvals